Bing

SEARCH HISTORY

Spectrum /quotes/zigman/89667 /quotes/nls/sppi SPPI plunged by nearly 36% to $7.97 in recent ... prompted WallachBeth analyst Difei Yang to cut his rating on the stock all the down to sell from buy. Yang also slashed his price target from $20 to $5.50.
Market Watch Commentary · ByRuss Britt · 3/13/2013
The stock market snapped its two-day skid with a Thursday advance ... MED, OMED, PETX, RMAX, TEAR, SPPI, EGY, RYI, CORT, SLW, FRPT Other notable movers on earnings/guidance: SEDG +11.8%, CALA +9.2%, HNSN +8.3%, DATA +8%, XOMA …
Briefing Live Market Analysis · 5/7/2015
Spectrum Pharmaceuticals is paying $30 million down and up to $320 million in cash and a million shares of stock for a significant share of the worldwide rights to a late-stage cancer compound advanced by TopoTarget A/S. Spectrum (SPPI) is putting up …
Fierce Biotech · ByJohn Carroll · 2/2/2010
More from Bing News
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the Company's …
Stockhouse · 5/28/2015
The ratio skew implies that investors are hedging their positions in anticipation of a stock move. Today's unusual volume activity confirms that traders are re-balancing their portfolios. Spectrum Pharmaceuticals (SPPI) opened today at $12.50 and is ...
AVAFIN · ByPeter Mankowitz · 8/17/2012
--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI ... may contain forward-looking statements regarding future events of Spectrum Pharmaceuticals and Allos Therapeutics that involve risks and uncertainties that could cause actual …
Business Wire · 5/24/2012
In an interview, Querubin's wife said their family started paying monthly installments to SPPI for the education plans of their ... Report from Maricar Bautista, ABS-CBN News
ABS-CBN News · 3/27/2009
Just minutes after Spectrum Pharmaceuticals (SPPI) announced an experimental cancer drug failed ... The proposed takeover values Allos at $1.82 a share, a 27% premium over the company's closing stock price Wednesday. The deal may be worth an …
Minyanville · ByBrett Chase · 4/5/2012
In recent months, a mini drama has been taking place on Wall Street, involving the managers of a small, prosperous biotechnology company called Spectrum Pharmaceuticals (SPPI), which I am ... their position against the stock on the basis of two …
globes.co.il · 6/30/2011
In other news, the company announced yesterday that it has commenced an underwritten public offering of $125 million of shares of its common stock. KYTH closed ... Spectrum Pharmaceuticals' (SPPI) New Drug Application for Captisol-Enabled …
Realtime Business News · 3/10/2015